Analysed MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) News Sources
Marvel Biosciences Announces Closing of Private Placement For Up To $3.0 Million
29-09-2026
yahoo.com
Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit
23-04-2026
yahoo.com
Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders
16-04-2026
yahoo.com
Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X
05-08-2026
yahoo.com
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
06-10-2026
yahoo.com
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
08-10-2026
yahoo.com
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
19-10-2026
yahoo.com
What is the current price of MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS)?
The current price of MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) is $0.0803.
MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) since the previous trading day is $0.
MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS)?
The most recent average sentiment score for MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) is 64 out of 100.
What is the most recent average sentiment for MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS)?
The most recent sentiment for MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS) is .
SEC-8K** Filing Available For MARVEL BIOSCIENCES CORP (MBCOF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.